JNJ-39220675

DB12929InvestigationalSmall molecule

JNJ-39220675 has been used in trials studying the treatment of Allergic Rhinitis.

Chemical structure of JNJ-39220675
Mechanism
Curator reviewed
Formula / weight
C21H24FN3O2 · 369.44 g/mol (avg)
Code names
JNJ-39220675

Resolves to

Compound
UNII41WC0AZ27VCAS959740-39-7ChEMBLCHEMBL1171754PubChem24771368
Structure
InChIKeyIQOWHZHNGJXGHG-UHFFFAOYSA-NSMILESFC1=CC=C(OC2=CC=C(C=N2)C(=O)N2CCCN(CC2)C2CCC2)C=C1
Targets
Q9Y5N1HRH3

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with JNJ-39220675, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In